Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1 [PDF]
, 2009 Owen T‐Y Tsang +14 more
openalex +1 more source
Variability in antifungal and antiviral use in hospitalized children [PDF]
, 2017 We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children’s hospitals. Antifungal and antiviral days of therapy varied across hospitals.
Gerber, Jeffrey S +6 more
core +2 more sources
Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis
International Journal of Infectious Diseases, 2019 Objectives: Lassa fever (LF) causes annual outbreaks in endemic regions with high mortality of symptomatic patients. Ribavirin is recommended as standard treatment for LF in national and international guidelines but the evidence base for this ...
Kirsten Alexandra Eberhardt +5 more
doaj +1 more source
In vitro and in vivo Phlebovirus inhibition by ribavirin [PDF]
, 1988 R. W. Sidwell +3 more
openalex +1 more source
A hepatitis C virus (HCV) fertőzés pathogenesise: a genetikai és az immunológiai tényezők, valamint az oxidativ stress szerepe és a kórokozó virus sajátosságai, különös tekintettel a HCV-okozta betegségekben és a tünetmentes virushordozó állapotban = Pathogenesis of hepatitis C virus (HCV) infection: the role of the genetic and immunological factors, the oxidative stress and the viral features in the HCV-related diseases and in the symptomfree virus carriers [PDF]
, 2009 Genetikai, immunológiai és környezeti tényezők potenciális szerepe krónikus hepatitis C virus (HCV) infekcióban: összehasonlitó vizsgálatok aktiv HCV hepatitises betegekben és tünetmentes "egészséges" virushordozókban. 1.
Berki, Timea +5 more
core
Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C [PDF]
, 2004 Monika Homoncik +7 more
openalex +1 more source
Modeling Ribavirin‐Induced Anemia in Patients with Chronic Hepatitis C Virus
CPT: Pharmacometrics & Systems Pharmacology, 2016 Ribavirin remains an important component of hepatitis C treatment in certain clinical scenarios, but it causes hemolytic anemia. A quantitative understanding of the ribavirin exposure‐anemia relationship is important in dose individualization ...
LS Wu +4 more
doaj +1 more source
Optimizing ribavirin dose in HIV/hepatitis C (HCV) co‐infected individuals treated for HCV [PDF]
, 2012 John Farley +4 more
openalex +1 more source
Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6 [PDF]
, 2016 Nattiya Kapol +2 more
openalex +1 more source
Market uptake of pegylated interferons for the treatment of hepatitis C in Europe : meeting abstract [PDF]
, 2008 Introduction and Objectives Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease with life threatening sequelae such as end-stage liver cirrhosis and liver cancer.
Lettmeier, Beate +5 more
core